ArticleHematology, transfusion and cell therapy

Lower doses of dacarbazine (modified BEACODD) as a safer strategy with equal effectiveness in an intensive treatment protocol of Hodgkin's lymphoma: a preliminary retrospective analysis of a single public center in Brazil.

Larissa Hilario Dulley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.